Clinical trials
Recruiting Phase 3 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 12 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 38 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Genmab | 3 |
| Beihua Kong | 2 |
| GlaxoSmithKline | 2 |
| AGO Study Group | 1 |
| ARCAGY/ GINECO GROUP | 1 |
| AstraZeneca | 1 |
| Centre Francois Baclesse | 1 |
| Charles University, Czech Republic | 1 |
| Chinese PLA General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 38 |
| Fallopian Tube Neoplasms | 11 |
| Carcinoma, Ovarian Epithelial | 4 |
| Recurrence | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Digestive System Diseases | 1 |
| Endometrial Neoplasms | 1 |
| Frailty | 1 |
| Kidney Neoplasms | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.